GSK to Acquire RAPT Therapeutics, Advancing Long-Acting IgE Therapy for Food Allergy Patients

GSK has agreed to acquire RAPT Therapeutics, adding a long-acting anti-IgE therapy…

Boehringer Ingelheim and LEO Pharma Enter Partnership to Commercialize and Further Develop SPEVIGO®

Boehringer Ingelheim and LEO Pharma today announced an exclusive global license and…

Kyverna Therapeutics Announces Appointment of New Chief Financial Officer

Kyverna Therapeutics, a clinical-stage biopharmaceutical company focused on developing cell therapies for…

Merck to Host Investor Event Highlighting Advances in HIV Treatment and Prevention Pipeline

Merck, known as MSD outside of the United States and Canada, announced…